Postmarketing Safety Events Relating to New Drugs Approved in Brazil Between 2003 and 2013: A Retrospective Cohort Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Postmarketing Safety Events Relating to New Drugs Approved in Brazil Between 2003 and 2013: A Retrospective Cohort Study

Published:2016-09-30 Issue:4 Volume:57 Page:493-499
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Botelho Stephanie Ferreira¹,Martins Maria Auxiliadora Parreiras²,Vieira Liliana Batista³,Reis Adriano Max Moreira²

Affiliation:

1. Universidade Federal de Minas Gerais Hospital Risoleta Tolentino Neves; R. das Gabirobas; Belo Horizonte Brazil

2. Universidade Federal de Minas Gerais; Faculdade de Farmácia; Av Antônio Carlos 6627 Pampulha, Belo Horizonte Brazil

3. Universidade Federal de Juiz de Fora; Departamento de Farmácia; Campus Governador Valadares; Universitário 35020220, Governador Valadares Brazil

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference40 articles.

1. A decade of safety-related regulatory action in the Netherlands: a retrospective analysis of direct healthcare professional communications from 1999 to 2009;Mol;Drug Saf,2010

2. Additional safety risk to exceptionally approved drugs in Europe?;Arnardottir;Br J Clin Pharmacol,2011

3. Post-approval safety issues with innovative drugs: a European cohort study;Mol;Drug Saf,2013

4. When direct health-care professional communications have an impact on inappropriate and unsafe use of medicines;Reber;Clin Pharmacol Ther,2013

5. Improving postapproval drug safety surveillance: getting better information sooner;Hennessy;Annu Rev Pharmacol Toxicol,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Postmarketing safety of orphan drugs: a longitudinal analysis of the US Food and Drug Administration database between 1999 and 2018;Orphanet Journal of Rare Diseases;2022-01-04

2. New drugs registered in Brazil from 2003 to 2013: analysis from the perspective of child health;Brazilian Journal of Pharmaceutical Sciences;2021

3. Thirteen years of medication alerts issued by the Brazilian Health Regulatory Agency (ANVISA): What is the profile?;Journal of Evaluation in Clinical Practice;2019-07-10

4. Suitability of new drugs registered in Brazil from 2003 to 2013 for pediatric age groups;Einstein (São Paulo);2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3